The overall goal of the Phase III MT COBRE is to ensure that the novel targets and compounds that have been identified by MT COBRE faculty are translated to pivotal human clinical trials. To that end, the Pilot Grant Program will have, as its major objective, the identification and initial funding of research projects to develop novel pre-clinical therapeutic agents identified by MT COBRE Program investigators. Although, the theme of this funding mechanism will be translational development of novel therapeutics and priority will be given to translational studies with a high potential for advancement to clinical studies, other meritorious grants may be funded as well. It is the intent that these developmental projects will lead to R01 and other competitive grant funding through expansion or re-direction of prior COBRE projects. The Pilot Grant Program will have a total 5-year budget of $1,725,000;comprised of $575,000 from the MT COBRE grant, $500,000 from the Executive Vice President for Research and $650,000 from the James Graham Brown Cancer Center discretionary funds (see detailed description, below). The applications will be solicited by an RFP process and will be reviewed by the MT COBRE Steering Committee.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
1P30GM106396-01
Application #
8543943
Study Section
Special Emphasis Panel (ZGM1-TWD-C (C3))
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
1
Fiscal Year
2013
Total Cost
$225,000
Indirect Cost
$75,000
Name
University of Louisville
Department
Type
DUNS #
057588857
City
Louisville
State
KY
Country
United States
Zip Code
40292
Zhao, Guoping; Neely, Aaron M; Schwarzer, Christian et al. (2016) N-(3-oxo-acyl) homoserine lactone inhibits tumor growth independent of Bcl-2 proteins. Oncotarget 7:5924-42
Smith, Colin A; Ban, David; Pratihar, Supriya et al. (2016) Allosteric switch regulates protein-protein binding through collective motion. Proc Natl Acad Sci U S A 113:3269-74
Garbett, Nichola C; Brock, Guy N (2016) Differential scanning calorimetry as a complementary diagnostic tool for the evaluation of biological samples. Biochim Biophys Acta 1860:981-9
Waigel, Sabine; Rendon, Beatriz E; Lamont, Gwyneth et al. (2016) MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes. Genom Data 7:240-2
Yaddanapudi, Kavitha; Rendon, Beatriz E; Lamont, Gwyneth et al. (2016) MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation. Cancer Immunol Res 4:101-12
Sabo, T Michael; Trent, John O; Lee, Donghan (2015) Population shuffling between ground and high energy excited states. Protein Sci 24:1714-9
England, Christopher G; Miller, M Clarke; Kuttan, Ashani et al. (2015) Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles. Eur J Pharm Biopharm 92:120-9
Miller, M Clarke; Ohrenberg, Carl J; Kuttan, Ashani et al. (2015) Separation of Quadruplex Polymorphism in DNA Sequences by Reversed-Phase Chromatography. Curr Protoc Nucleic Acid Chem 61:17.7.1-18
Satpathy, Shuchismita R; Jala, Venkatakrishna R; Bodduluri, Sobha R et al. (2015) Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth. Nat Commun 6:7064
Andreeva, Kalina; Soliman, Maha M; Cooper, Nigel G F (2015) Regulatory networks in retinal ischemia-reperfusion injury. BMC Genet 16:43

Showing the most recent 10 out of 46 publications